Lv11
98 积分 2024-03-05 加入
FDA Modernization Act 2.0 allows for alternatives to animal testing
1小时前
待确认
PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis
15天前
已完结
Application of the threshold of toxicological concern concept when applied to pharmaceutical manufacturing operations intended for short-term clinical trials
2个月前
已完结
Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients
2个月前
已完结
Background, approaches and recent trends for setting health-based occupational exposure limits: A minireview
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1年前
已完结
皖公网安备34019202002308
